Cargando…
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes
BACKGROUND: Inflammatory bowel diseases (IBD) are characterized by chronic relapsing inflammation of the gastrointestinal tract and encompass Crohn's disease and ulcerative colitis. IBD are often associated with extraintestinal manifestations affecting multiple organs including the liver. Incre...
Autores principales: | Mancina, Rosellina Margherita, Spagnuolo, Rocco, Milano, Marta, Brogneri, Simona, Morrone, Attilio, Cosco, Cristina, Lazzaro, Veronica, Russo, Cristina, Ferro, Yvelise, Pingitore, Piero, Pujia, Arturo, Montalcini, Tiziana, Doldo, Patrizia, Garieri, Pietro, Piodi, Luca, Caprioli, Flavio, Valenti, Luca, Romeo, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894778/ https://www.ncbi.nlm.nih.gov/pubmed/26355465 http://dx.doi.org/10.1097/MIB.0000000000000569 |
Ejemplares similares
-
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis
por: Pingitore, Piero, et al.
Publicado: (2016) -
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases
por: Spagnuolo, Rocco, et al.
Publicado: (2019) -
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
por: Pirazzi, Carlo, et al.
Publicado: (2014) -
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
por: Lindén, Daniel, et al.
Publicado: (2019) -
Individuals with Metabolically Healthy Overweight/Obesity Have Higher Fat Utilization than Metabolically Unhealthy Individuals
por: Pujia, Arturo, et al.
Publicado: (2016)